Dysregulation of EGFR signaling in cancer is often caused by mutations, amplifications, or overexpression, which results in increased cell proliferation, reduced apoptosis, and resistance to therapies like chemotherapy and radiation [110,111]. The gene discussed is EGFR; the disease is cancer.